-
Something wrong with this record ?
Clostridioides difficile epidemiology in the Middle and the Far East
M. Brajerova, J. Zikova, M. Krutova
Language English Country Great Britain
Document type Journal Article, Meta-Analysis, Review
- MeSH
- Anti-Bacterial Agents therapeutic use MeSH
- Clostridioides difficile * genetics MeSH
- Clostridioides MeSH
- Cross Infection * epidemiology MeSH
- Clostridium Infections * drug therapy epidemiology MeSH
- Humans MeSH
- Ribotyping MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Review MeSH
- Geographicals
- Asia, Eastern MeSH
OBJECTIVES: Clostridioides difficile is an important pathogen of healthcare-associated gastrointestinal infections. Recently, an increased number of C. difficile infection (CDI) surveillance data has been reported from Asia. The aim of this review is to summarize the data on the prevalence, distribution and molecular epidemiology of CDI in the Middle and the Far East. METHODS: Literature was drawn from a search of PubMed up to September 30, 2021. RESULTS: The meta-analysis of data from 111 studies revealed the pooled CDI prevalence rate in the Middle and the Far East of 12.4% (95% CI 11.4-13.3); 48 studies used PCR for CDI laboratory diagnoses. The predominant types (RT)/sequence type (ST) differ between individual countries (24 studies, 14 countries). Frequently found RTs were 001, 002, 012, 017, 018 and 126; RT017 was predominant in the Far East. The epidemic RT027 was detected in 8 countries (22 studies), but its predominance was reported only in three studies (Israel and Iran). The contamination of vegetable and meat or meat products and/or intestinal carriage of C. difficile in food and companion animals have been reported; the C. difficile RTs/STs identified overlapped with those identified in humans. CONCLUSIONS: A large number of studies on CDI prevalence in humans from the Middle and the Far East have been published; countries with no available data were identified. The number of studies on C. difficile from non-human sources is limited. Comparative genomic studies of isolates from different sources are needed.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018898
- 003
- CZ-PrNML
- 005
- 20220804135153.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.anaerobe.2022.102542 $2 doi
- 035 __
- $a (PubMed)35240336
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Brajerova, Marie $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Czech Republic
- 245 10
- $a Clostridioides difficile epidemiology in the Middle and the Far East / $c M. Brajerova, J. Zikova, M. Krutova
- 520 9_
- $a OBJECTIVES: Clostridioides difficile is an important pathogen of healthcare-associated gastrointestinal infections. Recently, an increased number of C. difficile infection (CDI) surveillance data has been reported from Asia. The aim of this review is to summarize the data on the prevalence, distribution and molecular epidemiology of CDI in the Middle and the Far East. METHODS: Literature was drawn from a search of PubMed up to September 30, 2021. RESULTS: The meta-analysis of data from 111 studies revealed the pooled CDI prevalence rate in the Middle and the Far East of 12.4% (95% CI 11.4-13.3); 48 studies used PCR for CDI laboratory diagnoses. The predominant types (RT)/sequence type (ST) differ between individual countries (24 studies, 14 countries). Frequently found RTs were 001, 002, 012, 017, 018 and 126; RT017 was predominant in the Far East. The epidemic RT027 was detected in 8 countries (22 studies), but its predominance was reported only in three studies (Israel and Iran). The contamination of vegetable and meat or meat products and/or intestinal carriage of C. difficile in food and companion animals have been reported; the C. difficile RTs/STs identified overlapped with those identified in humans. CONCLUSIONS: A large number of studies on CDI prevalence in humans from the Middle and the Far East have been published; countries with no available data were identified. The number of studies on C. difficile from non-human sources is limited. Comparative genomic studies of isolates from different sources are needed.
- 650 _2
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 650 _2
- $a Clostridioides $7 D000082682
- 650 12
- $a Clostridioides difficile $x genetika $7 D016360
- 650 12
- $a klostridiové infekce $x farmakoterapie $x epidemiologie $7 D003015
- 650 12
- $a infekce spojené se zdravotní péčí $x epidemiologie $7 D003428
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ribotypizace $7 D021521
- 651 _2
- $a Dálný východ $7 D005202
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Zikova, Jaroslava $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Czech Republic; Department of Genetics and Microbiology, Faculty of Science, Charles University, Czech Republic
- 700 1_
- $a Krutova, Marcela $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Czech Republic. Electronic address: marcela.krutova@lfmotol.cuni.cz
- 773 0_
- $w MED00006567 $t Anaerobe $x 1095-8274 $g Roč. 74, č. - (2022), s. 102542
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35240336 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135146 $b ABA008
- 999 __
- $a ok $b bmc $g 1822473 $s 1170141
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 74 $c - $d 102542 $e 20220228 $i 1095-8274 $m Anaerobe $n Anaerobe $x MED00006567
- LZP __
- $a Pubmed-20220720